Zdrowie i gospodarka · 29/05/2024
FDA Announces Availability of Draft Guidance for Platform Technology Designation Program
The Food and Drug Administration is releasing a draft guidance document outlining the details of the Platform Technology Designation Program for drug development, established by the PREVENT Pandemics Act, to provide clarity on eligibility, benefits, and the designation process.